| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A prognostic score for patients with malignant pleural mesothelioma (MPM) receiving second-line immunotherapy or chemotherapy in the ETOP 9–15 PROMISE-meso phase III trial
|
Banna, Giuseppe Luigi
|
|
|
169 |
C |
p. 77-83
|
artikel
|
| 2 |
Contents
|
|
|
|
169 |
C |
p. v-vi
|
artikel
|
| 3 |
Current state and upcoming opportunities for immunoPET biomarkers in lung cancer
|
Slebe, Maarten
|
|
|
169 |
C |
p. 84-93
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
169 |
C |
p. iii
|
artikel
|
| 5 |
Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-small cell lung cancer: Subgroup analysis of a global phase 2 trial
|
Soo, Ross A.
|
|
|
169 |
C |
p. 67-76
|
artikel
|
| 6 |
Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey
|
Pilotto, Sara
|
|
|
169 |
C |
p. 94-101
|
artikel
|
| 7 |
Health utilities for participants in a population-based sample who meet eligibility criteria for lung cancer screening
|
Ngo, Preston J.
|
|
|
169 |
C |
p. 47-54
|
artikel
|
| 8 |
Hospital case-volume and mortality after lung cancer surgery: A population-based retrospective cohort study
|
Kim, Bo Rim
|
|
|
169 |
C |
p. 61-66
|
artikel
|
| 9 |
Lymphocyte-to-monocyte ratio is an independent prognostic factor in surgically treated small cell lung cancer: An international multicenter analysis
|
Lang, Christian
|
|
|
169 |
C |
p. 40-46
|
artikel
|
| 10 |
Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcome
|
Mogenet, Alice
|
|
|
169 |
C |
p. 31-39
|
artikel
|
| 11 |
Neuroendocrine transformation from EGFR/ALK-wild type or TKI-naïve non-small cell lung cancer: An under-recognized phenomenon
|
Chu, Xiao
|
|
|
169 |
C |
p. 22-30
|
artikel
|
| 12 |
Race & sex disparities related to low-dose computed tomography lung cancer screening eligibility criteria: A lung cancer cases review
|
Williams, Randi M.
|
|
|
169 |
C |
p. 55-60
|
artikel
|
| 13 |
SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophils
|
Velut, Yoan
|
|
|
169 |
C |
p. 13-21
|
artikel
|
| 14 |
Targeting BRAF-mutant non-small cell lung cancer: Current status and future directions
|
Riudavets, Mariona
|
|
|
169 |
C |
p. 102-114
|
artikel
|
| 15 |
Tumour cell budding and spread through air spaces in squamous cell carcinoma of the lung – Determination and validation of optimal prognostic cut-offs
|
Stögbauer, Fabian
|
|
|
169 |
C |
p. 1-12
|
artikel
|
Tijdschrift beschrijving